- Home
- BMRN vs WBA Comparison
BMRN vs WBA Comparison
Compare BMRN & WBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRN
- WBA
- Stock Information
- Founded
- BMRN 1996
- WBA 1901
- Country
- BMRN United States
- WBA United States
- Employees
- BMRN N/A
- WBA N/A
- Industry
- BMRN Biotechnology: Pharmaceutical Preparations
- WBA Retail-Drug Stores and Proprietary Stores
- Sector
- BMRN Health Care
- WBA Consumer Staples
- Exchange
- BMRN Nasdaq
- WBA Nasdaq
- Market Cap
- BMRN 12.1B
- WBA 9.7B
- IPO Year
- BMRN 1999
- WBA N/A
- Fundamental
- Price
- BMRN $58.07
- WBA $11.25
- Analyst Decision
- BMRN Buy
- WBA Hold
- Analyst Count
- BMRN 22
- WBA 11
- Target Price
- BMRN $93.43
- WBA $10.59
- AVG Volume (30 Days)
- BMRN 2.2M
- WBA 11.7M
- Earning Date
- BMRN 05-01-2025
- WBA 06-26-2025
- Dividend Yield
- BMRN N/A
- WBA N/A
- EPS Growth
- BMRN 152.82
- WBA N/A
- EPS
- BMRN 2.71
- WBA N/A
- Revenue
- BMRN $2,950,227,000.00
- WBA $151,946,000,000.00
- Revenue This Year
- BMRN $12.27
- WBA $3.90
- Revenue Next Year
- BMRN $10.08
- WBA $1.88
- P/E Ratio
- BMRN $21.47
- WBA N/A
- Revenue Growth
- BMRN 19.36
- WBA 5.08
- 52 Week Low
- BMRN $52.93
- WBA $8.08
- 52 Week High
- BMRN $94.85
- WBA $16.34
- Technical
- Relative Strength Index (RSI)
- BMRN 41.32
- WBA 56.46
- Support Level
- BMRN $57.27
- WBA $11.10
- Resistance Level
- BMRN $59.12
- WBA $11.29
- Average True Range (ATR)
- BMRN 1.40
- WBA 0.12
- MACD
- BMRN 0.06
- WBA -0.01
- Stochastic Oscillator
- BMRN 18.34
- WBA 43.90
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.
About WBA Walgreens Boots Alliance Inc.
Walgreens Boots Alliance is one of the largest retail pharmacy chains in the US, with over 8,000 locations. Nearly three quarters of Americans live within five miles of a Walgreens location. Roughly two thirds of revenue is generated from prescription drug sales; Walgreens makes up 20% of total prescription revenue in the US. Walgreens also generates sales from retail products (general wellness consumables and its own branded merchandise), European drug wholesale, and healthcare. With more locations incorporating additional services like Health Corner and Village Medical, Walgreens creates an omnichannel experience for patients and positions itself as a one-stop healthcare provider.